 A number of approaches have been considered to amplify T cell mediated immune responses(e.g.IL-2, CTLA-4, IL-7, CD137), and some of these have shown clinical efficacy in eliminating particular types of cancer, most notably melanoma and renal cell carcinoma.The use of immunotransplant to enhance T cell-mediated immune responses, derive from studies of T cell homeostasis.